Clinical Trial Update: Plaque REgression With Cholesterol Absorption Inhibitor or Synthesis Inhibitor Evaluated by IntraVascular UltraSound [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluated plaque regression using either a cholesterol absorption inhibitor or a cholesterol synthesis inhibitor, assessed by intravasc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Hypercholesterolemia

Snippet

Sponsor: Kumamoto University | Conditions: Hypercholesterolemia, Coronary Artery Disease | Phase 4 | Status: COMPLETED